Ajdler Arnaud 4
4 · Recro Pharma, Inc. · Filed May 11, 2020
Insider Transaction Report
Form 4
Ajdler Arnaud
Director
Transactions
- Award
Common Stock
2020-05-07+8,363→ 23,757 total - Award
Stock Option (right to buy)
2020-05-07+12,405→ 12,405 totalExercise: $8.37Exp: 2030-05-07→ Common Stock (12,405 underlying)
Holdings
- 1,104,546(indirect: See footnote)
Common Stock
Footnotes (3)
- [F1]All shares of common stock are represented by unvested restricted stock units that will vest on May 7, 2021. Vested shares will be delivered to the reporting person within 30 days following the vesting date.
- [F2]The Reporting Person is the managing partner of Engine Capital Management, LP ("Engine Management") and the Managing Member of each of Engine Capital Management GP, LLC ("Engine Management GP") and Engine Investments, LLC ("Engine Investments"). Engine Management GP is the investment manager of Engine Capital, L.P. ("Engine Capital") and Engine Jet Capital, L.P. ("Engine Jet Capital"). Engine Capital and Engine Jet Capital own 907,578 and 196,968 shares of the Issuer's common stock, respectively. The Reporting Person disclaims beneficial ownership in such securities except to the extent of his pecuniary interest therein.
- [F3]The stock option will vest on May 7, 2021.